Bayer spends $100m on haemophilia development in Berkeley
Bayer has announced it will create a $100m (€94m) product testing site in California for its haemophilia A pipeline.
Archives for April 15, 2015
Dispatches from BPI 2015
Breakthrough barriers: Seeking fast track review means betting on data says Roche
To benefit from breakthrough therapy designation (BTD) pharma companies must be willing “bet on the right data” according to Roche, which says this could be a challenge for smaller firms.
Big firms dominate solubility sector but demand creating space for small players, says Kline & Co
BASF, Abitec and Gattefossé dominate the solubility excipients market but growing demand for tech to enhance API solubility is creating opportunities for smaller suppliers according to new research.
Catalent completes expansion of US complex tablet site
Catalent has doubled production capacity and added extra analytical lab space at its facility in Winchester, Kentucky, US.